Furthermore, another clinical trial of this vaccine demonstrated induction of a transient arthritis and dense CD4+ T lymphocytic vasculitis suggesting a pathophysiological role of vaccine-induced T lymphocytes. This evidence concerns the gene CD4 and arthritic joint disease.